tiprankstipranks
Trending News
More News >
Balaxi Pharmaceuticals Limited (IN:BALAXI)
:BALAXI
India Market

Balaxi Pharmaceuticals Limited (BALAXI) Financial Statements

Compare
0 Followers

Balaxi Pharmaceuticals Limited Financial Overview

Balaxi Pharmaceuticals Limited's market cap is currently ₹555.06M. The company's EPS TTM is ₹1.56; its P/E ratio is 11.08; Balaxi Pharmaceuticals Limited is scheduled to report earnings on May 30, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 2.89B₹ 2.41B₹ 3.36B₹ 2.79B₹ 2.31B
Gross Profit₹ 1.18B₹ 1.13B₹ 1.34B₹ 837.91M₹ 591.85M
Operating Income₹ 286.70M₹ 467.31M₹ 574.22M₹ 546.64M₹ 443.85M
EBITDA₹ 305.64M₹ 456.59M₹ 591.75M₹ 551.76M₹ 446.83M
Net Income₹ 250.70M₹ -23.87M₹ 459.63M₹ 476.58M₹ 381.37M
Balance Sheet
Cash & Short-Term Investments₹ 394.00M₹ 622.91M₹ 282.17M₹ 71.93M₹ 16.69M
Total Assets₹ 3.10B₹ 2.58B₹ 2.40B₹ 1.76B₹ 996.80M
Total Debt₹ 534.25M₹ 194.04M₹ 133.06M₹ 36.38M₹ 36.59M
Net Debt₹ 140.26M₹ -428.87M₹ -149.10M₹ -35.55M₹ 19.90M
Total Liabilities₹ 786.06M₹ 569.79M₹ 567.89M₹ 633.07M₹ 347.00M
Stockholders' Equity₹ 2.32B₹ 2.01B₹ 1.83B₹ 1.13B₹ 649.80M
Cash Flow
Free Cash Flow₹ -589.01M₹ 32.97M₹ -89.05M₹ 68.00M₹ -25.53M
Operating Cash Flow₹ -377.82M₹ 48.66M₹ 60.75M₹ 341.44M₹ 32.00K
Investing Cash Flow₹ -217.64M₹ -10.46M₹ -105.65M₹ -284.48M₹ -59.73M
Financing Cash Flow₹ 366.55M₹ 302.54M₹ 255.13M₹ -1.63M₹ 36.46M
Currency in INR

Balaxi Pharmaceuticals Limited Earnings and Revenue History

Balaxi Pharmaceuticals Limited Debt to Assets

Balaxi Pharmaceuticals Limited Cash Flow

Balaxi Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis